Data / Form D filings / Bionpharma Inc.
Bionpharma Inc.: Form D filings
Bionpharma Inc., a pharmaceuticals company in Princeton, NJ, filed 4 Form D notices with the SEC between 2014 and 2015. The latest, on December 15, 2015, reports $6.5 million sold of a $6.5 million offering to 1 investor.
Find out what Bionpharma Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 600 ALEXANDER ROAD, SUITE 2-4B, Princeton, NJ, 08540
- Phone
- (609) 380-3310
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1624663
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 15, 2015 | New notice | $6,500,000 | $6,500,000 | $0 | 1 | Dec 1, 2015 | sec.gov |
| May 27, 2015 | Amendment | $30,668,000 | $30,668,000 | $0 | 10 | Nov 3, 2014 | sec.gov |
| Feb 4, 2015 | Amendment | $30,000,000 | $30,000,000 | $0 | 3 | Nov 3, 2014 | sec.gov |
| Nov 13, 2014 | New notice | $30,000,000 | $21,275,000 | $8,725,000 | 2 | Nov 3, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard W. Van Duyne | Director | |
| Venkatachalam Krishnan | Executive Officer, Director | |
| James Gale | Director | |
| Carol S. Ben-Maimon | Director | |
| David W. Goodman | Director | |
| Lavesh W. Samtani | Executive Officer | |
| Gaurav W. Mehrotra | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Dec 14, 2015 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Bionpharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.